跳至主要内容
临床试验/NCT03018613
NCT03018613Unknown1 期

Evaluation of the Effect of Fecal Microbiota Transplantation on Chronic Functional Constipation and Its Mechanism

First Affiliated Hospital of Chengdu Medical College2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年7月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
60
试验地点
2
主要终点
Number of adverse events complication rate in all patients in both groups

研究概览

简要总结

Chronic functional constipation is a common digestive system disease, the incidence is increasing in recent years.It is reported that the occurrence and development of chronic functional constipation is closely related to imbalance of intestinal flora .Moreover,types and quantity of intestinal flora may be related to intestinal motility. Fecal microbiota transplantation as a new technology to rebuild intestinal flora has been used for several disease,but the clinical efficacy of chronic functional constipation by fecal microbiota transplantation needs to be further explored.

详细描述

Patients who meet the inclusion crit chronic functional constipation will be separated into two parts depending on acceptation or refuse of Fecal microbiota transplantation.Blood specimen from patients will be collected to analysis intestinal motility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects voluntarily participate in the trial and sign informed consent;
  • sex is not limited,ranging from 18 to 75 years old;
  • meet the diagnostic criteria for chronic functional constipation in patients;
  • patients has been ruled out organic diseases of the large intestine within 1 year by colonoscopy or barium enema examination, and stool routine and occult blood examination are normal within 1 month;
  • be able to communicate well with the researchers and follow the verification requirements.

排除标准

  • does not meet the diagnostic criteria;
  • with severe primary heart, liver, lung, kidney, blood or affect the survival of serious diseases;
  • severe anemia and severe systemic infection;
  • suspected or indeed have alcohol, drug abuse history;
  • pregnancy or are preparing for pregnancy, and breastfeeding women;
  • Those who are unwilling to accept the research measures or other reasons can not cooperate;
  • due to mental disorders can not give adequate informed consent;
  • Participated in other clinical trials within 3 months before the start of the study;
  • researchers believe that participates are not suitable for other reasons in this clinical trial.

结局指标

主要结局

Number of adverse events complication rate in all patients in both groups

时间窗: 3 months

次要结局

  • Microbiota composition(4 weeks)
  • Nitric oxide(NO)(4 weeks)
  • Mean number of bowel movements per week(4 weeks)
  • Bristol stool scale(4 weeks)
  • Constipation-related symptoms assessments(4 weeks)
  • Usage of laxatives or enemas as rescue medication(4 weeks)
  • Histological changes in the intestinal biopsy in both groups.(4 weeks)

研究者

发起方
First Affiliated Hospital of Chengdu Medical College
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Fecal Microbiota Transplantation for Chronic... | 临床试验